BRCA1 and triple-negative breast carcinoma: Ten cell lines were analyzed: one benign breast epithelium-derived cell line (MCF10a), two luminal breast cancer-derived cell lines (MCF7, T47D) and seven triple-negative breast cancer-derived cell lines (MDA-MB-231, MDA-MB-436, HCC1937, SUM149PT, SUM1315MO2, SUM1315-BRCA1 and SUM1315-LXSN).